Shanghai Junshi Biosciences Co., Ltd. Class H (1877) Stock Statistics & Valuation Metrics

Shanghai Junshi Biosciences Co., Ltd. Class H has a market cap or net worth of HK$42.93B. The enterprise value is HK$21.29B.

Shanghai Junshi Biosciences Co., Ltd. Class H has 260,295,700 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shanghai Junshi Biosciences Co., Ltd. Class H’s return on equity (ROE) is -0.22 and return on invested capital (ROIC) is -14.74%.

The current PE Ratio of Shanghai Junshi Biosciences Co., Ltd. Class H is ―. Shanghai Junshi Biosciences Co., Ltd. Class H’s PEG ratio is 0.19.

In the last 12 months, Shanghai Junshi Biosciences Co., Ltd. Class H had revenue of 1.95B and earned -1.28B in profits. Earnings per share was -1.30.

In the last 12 months, operating cash flow was -897.88M and capital expenditures -609.03M, giving a free cash flow of -1.51B billion.

Shanghai Junshi Biosciences Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―

Shanghai Junshi Biosciences Co., Ltd. Class H upcoming earnings date is Oct 24, 2025, TBA (Confirmed).

Shanghai Junshi Biosciences Co., Ltd. Class H as a current ratio of 1.72, with Debt / Equity ratio of 54.82%

In the past 12 months, Shanghai Junshi Biosciences Co., Ltd. Class H has paid 22.55M in taxes.

Shanghai Junshi Biosciences Co., Ltd. Class H EV to EBITDA ratio is -11.91, with an EV/FCF ratio of -5.25.

Shanghai Junshi Biosciences Co., Ltd. Class H has HK$3.51B in cash and marketable securities with HK$3.49B in debt, giving a net cash position of HK$13.59M billion.

Gross margin is 78.09%, with operating margin of -68.72%, and net profit margin of -65.75%.

The average price target for Shanghai Junshi Biosciences Co., Ltd. Class H is HK$28.23, which is 11.43% higher than the current price. The consensus rating is Hold